MedPath

Evaluating the comfort, vision and fit of Ocutec daily disposable contact lenses in comparison with Acuvue OASYS contact lenses.

Not Applicable
Conditions
earsightedness and farsightedness
Eye Diseases
Myopia and hyperopia
Registration Number
ISRCTN21794264
Lead Sponsor
Ocutec Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
30
Inclusion Criteria

1. =18 years old
2. Willing to wear supplied over-spectacle correction if required
3. Be existing soft contact lens wearers (at least 4 weeks daily wear prior to study)
4. Require a visual correction in both eyes (monovision allowed but no monofit)
5. Have a spherical contact lens requirement in the range of -1.00D to -4.00D
6. Have no greater than 1.00D difference in contact lens spherical requirement between eyes
7. Have astigmatism <1.25D in both eyes
8. Monocular distance visual acuity correctable to 6/9 (20/30) or better in each eye with best sphero-cylindrical refraction
9. Have normal eyes with no evidence of any ocular abnormality or disease. For the purposes of this study a normal eye is defined as:
9.1. Having clear central corneas
9.2. No anterior segment disorder
9.3. No clinically significant slit lamp findings (i.e. corneal oedema, staining, central scarring, infiltrates, active neovascularisation)
9.4. No other active ocular disease or recent surgery.

Exclusion Criteria

1. Any systemic disease affecting ocular health
2. Any systemic or topical medications that will in the investigator’s opinion affect ocular physiology or contact lens performance
3. Severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses
4. Persistent, clinically significant corneal or conjunctival staining using fluorescein dye (= Grade 3)
5. Aphakic
6. Undergone corneal refractive surgery
7. Participating in any other type of eye related clinical or research study
8. Pregnancy, lactating or planning a pregnancy at the time of enrollment
9. Participation in any trial within the last 14 days

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath